Beta Finch - S&P 100 - EN

More earnings analysis: https://betafinch.com
Groups: INDUSTRIALS (https://betafinch.com/groups/INDUSTRIALS)
──────────
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we take the dense stuff from earnings calls and turn it into something you'd actually want to listen to. I'm Alex.

**JORDAN:** And I'm Jordan. And Alex, before we get into today's company, we gotta say this.

**ALEX:** Right. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Okay, with that out of the way — today we're talking GE Aerospace, ticker GE, Q3 2026 results, reported October 20th.

**ALEX:** And Jordan, I'll just say it — this was a genuinely blowout quarter. Orders up 49% company-wide. Revenue up 18%. Operating profit up 30%. EPS up 36%. If you're an investor in this name, that's about as clean a sweep as you can ask for.

**JORDAN:** It really is. And the engine — pun intended — behind all of it is their Commercial Engines and Services segment, CES. Orders there were up 58%. Services orders alone, up 23% in the quarter, 30% year-to-date. That's the sixth straight quarter of at least 20% revenue growth in that segment.

**ALEX:** Six quarters! That's not a blip, that's a trend. And it's being driven by this massive backlog — over $170 billion now. CEO Larry Culp talked about the Farnborough Airshow where they locked in commitments for more than 1,800 engines, including that IndiGo deal — the largest LEAP engine agreement ever, over 1,000 engines for their A320neo fleet.

**JORDAN:** And just last week, before this call even happened, they announced Turkish Airlines — over 300 LEAP-1B engines plus a long-term service deal covering their entire 600-plus engine fleet. So the order book just keeps stacking up.

**ALEX:** Let's talk numbers a bit more. CFO Rahul Ghai broke down margins — 22.5% operating margin, up 220 basis points year-over-year. Free cash flow came in over $2 billion for the quarter, $6.7 billion year-to-date, which is 105% conversion of earnings into cash. That's a really healthy number.

**JORDAN:** And because of all this strength, they raised full-year 2026 guidance across the board. Revenue growth now expected at 19-20%, up from high teens. EPS guidance bumped to $8 to $8.10, up 30 cents at the midpoint. Free cash flow guidance raised to $9.1 to $9.4 billion.

**ALEX:** And here's the one that really jumped out to me — they gave an early look at 2027, guiding to low double-digit growth in commercial services. That's based on the sheer size of that backlog and engines that are already flying and will need shop visits.

**JORDAN:** Right, and this is where it gets interesting operationally. They're using something called "Flight Deck" — their lean operating system — to attack bottlenecks. One example: they reoriented a LEAP fan assembly production line and more than doubled output just through better workflow design, not new equipment.

**ALEX:** And there's an AI angle too, which feels very on-brand for 2026. At their Celma MRO site in Brazil, they built an AI tool to automate technical records collection for CFM56 engine shop visits — cut processing time by about 25%.

**JORDAN:** That stuff matters more than people realize. Turnaround times on shop visits are down over a week since the end of last year, LEAP specifically down two weeks. And probably the headline operational win — LEAP-related grounded aircraft, the AOG number, is down to near zero since summer. That's been a persistent pain point for airlines, so that's a real customer-facing win.

**ALEX:** Big strategic news too — the agreement to acquire Consolidated Precision Products, or CPP. This is about securing capacity for mission-critical castings industry-wide, and also accelerating next-gen engine cooling technology. Culp mention

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
──────────
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown! Today we're digging into Prologis — ticker PLD — the industrial real estate giant that basically owns the warehouses behind your Amazon packages. Q3 2026 results dropped, and there's a lot to unpack, including a massive European merger clearing a huge hurdle.

**JORDAN:** Big one. But before we get into it...

**ALEX:** Right, gotta say it. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Perfect. Now let's talk warehouses.

**ALEX:** So, headline numbers first. Prologis posted core FFO — that's funds from operations, basically the REIT version of earnings — of $1.60 per share, or $1.61 excluding some promote expenses. Occupancy ticked up to 95.6%, same-store NOI growth came in at 5.7% on a net effective basis, 5.9% on cash. And get this — rent change on rollover, meaning when an old lease expires and they sign a new one, was 38% net effective.

**JORDAN:** That 38% number is the one that jumps out at me. That's the "mark-to-market" story playing out in real time — Prologis signed a ton of leases years ago at much lower rents, and now as those roll over, they're repricing at a huge premium. They said their portfolio-wide lease mark-to-market sits at 16%, representing about $780 million of embedded NOI just waiting to flow through in future years. That's a built-in growth engine regardless of what the broader market does next.

**ALEX:** And they raised guidance because of it. Same-store NOI growth guidance moved up to 5.5%–6% net effective, 7%–7.5% on cash. They also bumped development starts guidance to $6 billion–$6.75 billion for the year, which actually surprised some analysts on the call given everything they said about rising construction costs.

**JORDAN:** Yeah, that was a good tension point in the Q&A. Dan Letter, the CEO, basically explained it: a lot of that increase is build-to-suit projects — meaning a specific customer has already committed to a building before it's even built. He said build-to-suits could be 55% to 65% of total starts this year, and the build-to-suit pipeline is 20-25% bigger than it was a year ago. So it's not that Prologis is getting more aggressive speculatively — it's that demand, particularly from data center supply chain customers, is pulling specific projects forward.

**ALEX:** Which brings us to the two biggest strategic stories of the quarter. First — SEGRO. Can you break that down?

**JORDAN:** So SEGRO is a major European logistics REIT, and Prologis has been working on combining with them. The huge update this quarter: SEGRO shareholders overwhelmingly approved the deal on September 28th. It's now moving through regulatory clearance, with an expected close in the first half of 2027. Once it closes, combined, they'll have a 368-million-square-foot European portfolio — massive scale advantage for serving customers and building out both logistics and data centers across Europe.

**ALEX:** And they already raised $2.4 billion in common equity to help fund part of that consideration, so a chunk of the capital stack is locked in. CFO Tim Arndt made a point of saying 2027 guidance — which comes out in January — probably won't even include SEGRO specifics yet since the deal likely won't have closed by then.

**JORDAN:** Smart to manage expectations there. The second big story, and honestly the one I think long-term investors should watch closest, is data centers. Prologis's pipeline is now 5.8 gigawatts — 1.7 gigawatts of secured power and 4.1 in advanced stages. They've got letters of intent covering about 1 gigawatt, with much of that expected to start in 2027.

**ALEX:** And it's not just the direct data center business — they flagged that customers

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
──────────
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown, where we take the transcripts so you don't have to. I'm Alex.

JORDAN: And I'm Jordan. Alex, before we get into it—U.S. Bancorp just posted a pretty strong quarter.

ALEX: They did, and we're going to dig into all of it. But first, our standard reminder: this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Solid. Okay, so let's talk numbers. U.S. Bancorp—ticker USB—reported Q3 2026 results on October 15th, and the headline is record net revenue of about $8 billion.

ALEX: Right, and diluted EPS came in at $1.34, up roughly 10% year-over-year. CEO Gunjan Kedia and CFO John Stern were both pretty upbeat on the call.

JORDAN: What stood out to me was the operating leverage number—240 basis points positive, and excluding the BTIG acquisition, it's actually 440 basis points. That's a big efficiency win.

ALEX: Yeah, and revenue growth of 8.7% year-over-year outpaced expense growth of 7.1%. So they're growing the top line faster than costs, which is exactly what you want to see from a bank focused on productivity.

JORDAN: Let's talk about BTIG, because that's clearly a big strategic piece here. U.S. Bancorp closed that acquisition back in June, and it already contributed $226 million in fee revenue this quarter.

ALEX: And management's ambition here is pretty bold—they want capital markets to grow from about 8% of total company revenue to 10% or more over the next three to five years.

JORDAN: Legacy capital markets also grew 10% on its own, and combined with BTIG, total capital markets revenue was up 69% year-over-year. That's a really strong combination quarter.

ALEX: Let's shift to the balance sheet side, because this is where things get interesting for income investors. Net interest margin expanded 5 basis points sequentially to 2.84%, and management expects a similar bump in Q4.

JORDAN: And there's a longer-term thesis here too—CFO John Stern talked about a path to a 3% NIM at some point in 2027. The engine behind that is this ongoing shift toward asset sensitivity. Floating-rate loans now make up 30% of earning assets, up from just 22% four years ago.

ALEX: That's a meaningful shift. Basically, they're leaning into commercial and industrial loans, commercial real estate, and credit cards—all more floating-rate in nature—while being more measured on fixed-rate stuff like residential mortgage and auto.

JORDAN: Speaking of credit cards, can we talk about the Amazon small business co-brand partnership? That's a new one.

ALEX: Yeah, this quarter they onboarded it, and it already added about $900 million to average loans and $1.7 billion to period-end loans. That's going to be a nice tailwind heading into Q4 since they'll get the full quarter's impact.

JORDAN: And it fits into this broader small business push—they're serving more than 2 million small businesses now, they brought in Jessica Alba as a brand ambassador for that segment, and they're clearly treating this as a strategic priority heading into 2027.

ALEX: Let's get into guidance, because management actually raised it this quarter. For full-year 2026, they now expect total net revenue growth of 8% to 9%, up from the prior 5% to 7% range.

JORDAN: And operating leverage guidance moved up too—now approximately 300 basis points for the full year, or 400 basis points excluding BTIG. That's up from the previous 200 to 300 basis point guide. So they're not just beating expectations, they're raising the bar for themselves.

ALEX: Now, let's hit some of the more interesting Q&A moments, because there were a few. One thing that jumped out—analysts pressed hard on share buybacks. USB paused repurchases recently, and CFO John Stern explained that was

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
Groups: BANKS (https://betafinch.com/groups/BANKS)
──────────
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex.

JORDAN: And I'm Jordan. Alex, we've got a meaty one today — Charles Schwab's Q3 2026 results.

ALEX: We do, and before we dive in — quick disclosure. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Good, got that out of the way. Because honestly, Alex, this Schwab print had a lot going on — record numbers, AI partnerships, crypto, even prediction markets.

ALEX: Prediction markets! We'll absolutely get there. But let's start with the headline numbers because they were genuinely strong. Total net revenue hit $7.2 billion, up 17% year-over-year — a record. Adjusted EPS came in at $1.69, up 29% from last year.

JORDAN: Twenty-nine percent EPS growth is not a typo. That's the kind of number that makes you sit up. And the pre-tax margin expanded to 54.8%, up about 350 basis points year-over-year. So they're not just growing revenue — they're getting more efficient while doing it.

ALEX: Right, and that efficiency story is actually a theme we should flag early, because CFO Mike Verdeschi mentioned they're now expecting roughly 800 basis points of positive operating leverage for the full year — which he said is about double what they expected at the start of 2026.

JORDAN: That's a huge beat on their own internal expectations. Let's talk about where the growth is actually coming from, though, because it's not just market appreciation lifting all boats.

ALEX: No, this is organic. Core net new assets — that's money clients are actually moving into Schwab, not just market gains — came in at $190 billion for the quarter. That's up 38% over last year.

JORDAN: And clients opened 1.2 million new brokerage accounts in the quarter alone. CEO Rick Wurster made a point of saying growth is broad-based — retail, RIA advisors, workplace plans — all three channels firing at once.

ALEX: The lending side really stood out to me too. Bank lending reached $72.3 billion, up 35% year-over-year, driven mostly by their Pledged Asset Line product. And here's the interesting wrinkle — loan growth actually outpaced deposit growth this quarter.

JORDAN: Which matters because it means Schwab had to lean more on diversified wholesale funding sources to support all that lending demand. It's not a red flag, but it is a shift in balance sheet composition worth watching. Verdeschi framed it as a good problem to have — clients are more engaged, borrowing more, which is actually more profitable for Schwab than just sitting on low-yield securities.

ALEX: Right, he made that point explicitly — they've got about $190 billion of older securities still yielding under 2%, and as that rolls off, redeploying into lending or even just current-rate securities is going to be a tailwind for net interest margin heading into 2027.

JORDAN: Speaking of NIM, they guided to NIM growing toward the lower end of their previously provided range for the year, and expense growth coming in at the low end too. So revenue slightly softer than best-case, but expenses also well-controlled. Net-net, still a strong setup.

ALEX: Now let's get into the stuff that got analysts buzzing on the call — AI. Schwab is leaning hard into this. They've partnered with Anthropic, becoming the first RIA custodian included in Claude for Financial Advisors. And they launched their own AI assistant called Charlie.

JORDAN: Charlie's interesting because right now it's mostly informational — answering questions, handling simple admin tasks like updating an address. But Wurster was clear: over time, Charlie becomes basically the "front door" to Schwab.

ALEX: And internally, they said AI has already made their developers

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
Groups: BANKS (https://betafinch.com/groups/BANKS)
──────────
WELCOME TO BETA FINCH, your AI-powered earnings breakdown. Today we're digging into Wells Fargo's third quarter 2026 results, and there's a lot to unpack.

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, joined as always by Jordan. Before we dive in — this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions. Okay, Jordan, Wells Fargo posted its Q3 2026 numbers, and honestly, the headline is pretty strong.

JORDAN: Yeah, EPS came in at $1.87, up 13% year-over-year. And the number that really jumps out to me is ROTCE — return on tangible common equity — hitting 16.3% for the quarter. That's a bank steadily climbing toward its 17-18% target.

ALEX: Right, and this wasn't one segment carrying the whole load. Revenue grew 2% overall, but Wealth and Investment Management was up 12%, Commercial Banking up 6%, Consumer Banking up 5%, and the Corporate and Investment Bank up 3%.

JORDAN: That broad-based growth is the story here. Average loans and deposits both up 11% year-over-year. And they're doing it while actually cutting headcount — down 8% year-over-year, the sixth straight year of declines. Efficiency ratio improved to 63%.

ALEX: CEO Charlie Scharf made a point of saying expenses declined even as revenue-related costs — think commissions — rose 15%. They offset that with a 4% drop in non-revenue expenses.

JORDAN: That's the efficiency story playing out in real time. Now, let's talk strategy, because there were a couple of genuinely interesting announcements buried in here. Tokenized deposits on their own blockchain platform.

ALEX: Right, this launched last month. CFO Mike Santomassimo explained the real use case — cross-border payments. Instead of taking a day or two, transactions are settling in two minutes or less, in production right now, albeit small volume.

JORDAN: And they're not stopping there — Wells is joining 20 other international banks to launch a stablecoin venture starting in the first half of 2027. Scharf was careful to say the U.S. stablecoin use case is "unclear" still, but they want to be positioned.

ALEX: They're also leaning hard into AI — not just customer-facing tools like an AI assistant for financial advisers, but internally for coding, cybersecurity, risk management. Scharf made an interesting point about scale during the Q&A.

JORDAN: Yeah, that was one of my favorite moments. He basically said everyone talks about AI agents disrupting banking, but he thinks there's an underappreciated advantage for big banks with scale — you build one tool and deploy it across a massive customer base or operations footprint. Cost stays the same, benefit multiplies.

ALEX: He also pushed back hard on the idea that AI agents will cause "deposit flight" — people letting bots shop their deposits around for better rates.

JORDAN: Right, an analyst asked about that directly, and Scharf basically said: that capability already exists, people can move money online today if they want to, and most don't — because checking accounts, payroll, and relationship banking matter more than chasing the last basis point. He called the deposit-flight fear "completely overdone."

ALEX: Let's talk credit quality, because that's always the thing investors worry about in a higher-rate environment.

JORDAN: Credit actually looked clean. Net charge-off ratio was 38 basis points, down year-over-year. Consumer charge-offs declined to 70 basis points. Commercial losses ticked up slightly to 18 basis points but management called it idiosyncratic, not systemic — no broad deterioration.

ALEX: They did flag commercial real estate as a watch item — higher rates mechanically pressure valuations — but Santomassimo said it's

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
Groups: HEALTHCARE (https://betafinch.com/groups/HEALTHCARE)
──────────
WELCOME TO BETA FINCH

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown, where we take the numbers and the jargon from corporate earnings calls and turn them into something you can actually digest. I'm Alex.

JORDAN: And I'm Jordan. Today we're diving into UnitedHealth Group — ticker UNH — and their third quarter 2026 results, reported this week.

ALEX: Before we get into it, quick disclaimer: this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Good to have that out front. So Alex, this was actually a pretty encouraging quarter for UnitedHealth after a rough stretch.

ALEX: It really was. Let's start with the headline numbers. Revenue came in at $113 billion for the quarter. Adjusted earnings per share was $4.69 — compare that to just $2.92 a year ago. That's a massive jump.

JORDAN: And the metric everyone watches in this industry, the medical care ratio — basically what percentage of premium revenue goes out the door paying for medical claims — improved to 88.4%, down from 89.9% last year. Lower is better here, it means they're managing costs more effectively relative to what they're bringing in.

ALEX: Right, and on the back of that they raised full-year guidance to at least $20.50 in adjusted EPS. CFO Wayne DeVeydt called that a "solid run rate to grow from," and interestingly, management said they think Wall Street's 2027 estimates might actually be too conservative.

JORDAN: That's a confident thing to say out loud on an earnings call. They're essentially telling analysts, "you might be underestimating us."

ALEX: Let's talk segments for a second. UnitedHealthcare, the insurance arm, served 48.3 million people. Optum, their services arm, posted $66.9 billion in revenue — though Optum Health specifically saw a 10% revenue decline, which sounds alarming at first.

JORDAN: It does, but context matters. That's really a reflection of them pulling back from certain full-risk arrangements and refocusing on more disciplined, value-based care contracts rather than just chasing volume. Quality over quantity, essentially.

ALEX: Now here's the thing that jumped out at me — commercial medical trend, meaning cost growth in their employer-sponsored insurance business, is running above 11%. That's way above historical norms.

JORDAN: And they were pretty pointed about why. Two big drivers: high-cost specialty drugs, which is an industry-wide story at this point, and something more unique to UnitedHealth's commentary — arbitration awards tied to the No Surprises Act.

ALEX: Explain that one, because it's a little wonky.

JORDAN: Sure. The No Surprises Act was designed to protect patients from surprise out-of-network bills. But there's a dispute resolution process built into it, and UnitedHealth is saying certain provider groups are gaming that process — arbitration awards in some regions are approaching 6% of total medical spend. Management was blunt, calling it "abuse" of the system, and said it's translating to billions in excess costs.

ALEX: So this isn't just "healthcare costs are high," it's "there's a specific regulatory mechanism being exploited."

JORDAN: Exactly, and they're actively lobbying regulators on it. Worth watching into 2027.

ALEX: Let's shift to the strategic story, because this is where it gets interesting. CEO Steve Hemsley leaned hard into AI throughout the call. They've rolled out AI-enabled chart summarization to over 40% of employed clinicians, cutting chart review time by a third. AI-assisted appeals processing cut cycle times by 26%.

JORDAN: And the big one for anyone who's ever dealt with insurance red tape — they're on track to cut prior authorization volumes by 30%

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
Groups: BANKS (https://betafinch.com/groups/BANKS)
──────────
WELCOME TO BETA FINCH

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, joined as always by Jordan, and today we're digging into Morgan Stanley's third quarter 2026 results, reported this week.

JORDAN: Lots to get into here, Alex — record wealth assets, a scorching equities business, and some pretty candid commentary from CEO Ted Pick on the AI buildout.

ALEX: Before we jump in, quick disclaimer: this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Noted and agreed. Okay, let's talk numbers.

ALEX: Morgan Stanley posted firm-wide revenue of $20.3 billion for Q3, with earnings per share of $3.03 — and I believe that figure got mangled in the transcript as "$30.03," so just to be clear for listeners, it's $3.03 a share.

JORDAN: Right, and the headline stat that really jumps out is return on tangible equity at 22.6%. That's the fifth straight quarter above 20%, which management leaned on hard as proof this isn't a one-off hot streak — it's a sustained operating model.

ALEX: Let's start with wealth management, because the numbers there are genuinely eye-popping. Total client assets across wealth and investment management hit a record $10.5 trillion, up $400 billion in just one quarter. Wealth management revenue alone was over $9 billion — also a record — with net new assets of $232 billion and fee-based flows of $80 billion.

JORDAN: That $232 billion net-new-assets number is the one analysts kept circling back to in the Q&A. CFO Sharon Yeshaya explained it's not just a one-quarter IPO pop — it's a "tail" effect. Early investors, employees, and funds from prior IPOs keep funneling assets into Morgan Stanley's advisory relationships over time, sometimes months or years after the actual IPO happened.

ALEX: And Ted Pick made a point of zooming out on that — since acquiring E*TRADE six years ago, they've pulled in over $2 trillion in net new assets, with the last two three-year stretches each adding roughly $1 trillion. His argument is basically "scale begets scale" — the self-directed channel, the workplace/corporate stock plan business, and financial advisors all feed each other.

JORDAN: It's a nice flywheel story. Now let's talk about the institutional side, because Equities had an absolute monster quarter — $5.8 billion in revenue, up 41% year-over-year. Institutional Securities overall was $10 billion, up 18%.

ALEX: Investment banking was more modest — up just 2% to $2.2 billion — with advisory revenue of $887 million doing the heavy lifting, while equity underwriting actually declined. Fixed income underwriting stayed strong at $747 million.

JORDAN: What struck me in the prepared remarks was Pick's framing of the quarter as having "two distinct phases." July and August were red-hot, driven by hyperscaler AI spending. Then after Labor Day, things cooled — Middle East tensions flared back up, rates moved higher, and trading volumes slowed into September.

ALEX: That "glass half full, glass half empty" framework he used was probably the most quotable moment of the call. On the bullish side: AI capital deployment driving 5-6% nominal GDP growth, strong corporate earnings, full employment. On the bearish side: ongoing geopolitical conflict, higher benchmark rates, elevated equity valuations four years into a bull market, and election uncertainty.

JORDAN: And he was asked directly — is Morgan Stanley leaning more or less into AI given those risks? His answer was blunt: they were already "overweight," and now they're "double overweight." He framed it as existential — Morgan Stanley wants to be the trusted advisor sitting in the middle of the entire AI financing ecosystem, whether that's h

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
Groups: BANKS (https://betafinch.com/groups/BANKS)
──────────
**WELCOME TO BETA FINCH — JPMORGAN CHASE (JPM) Q3 2026**

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, joined as always by Jordan, and today we're digging into JPMorgan Chase's third-quarter 2026 results. Before we get into it, a quick note — this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Alright, and there's a lot to dig into here, Alex. JPMorgan is just... firing on all cylinders right now.

ALEX: It really is. Let's start with the headline numbers. Net income came in at $15.3 billion, EPS of $5.57, and return on tangible common equity of 20%. Revenue was $50.9 billion, up 8% year over year — and up 9% if you strip out some one-time investment securities losses in the corporate segment.

JORDAN: And the growth was broad-based. Card volumes were up, investment banking fees jumped 14% year over year — notably in advisory — and asset and wealth management saw $51 billion in long-term net inflows. AUM crossed $5.2 trillion, up 13%. This isn't a one-business story.

ALEX: Right, and CFO Jeremy Barnum actually said something pretty striking on the call — that basically every single business segment is performing above historical norms simultaneously. Jamie Dimon echoed that too, saying "every single business is performing exceptionally well."

JORDAN: Which, historically, is unusual. Normally you'd see some segments outperform while others lag depending on the rate environment. Barnum pointed out that's just not the pattern right now — everything's humming at once. Expenses did rise 12% year over year to $27.3 billion, mostly from volume-related costs and hiring, but that's the cost of doing more business, not a red flag.

ALEX: Let's talk guidance, because this is where it gets interesting. For Q4, they're guiding to NII ex-markets of about $25.5 billion and total NII around $28 billion. But the big one — they gave a preliminary 2027 central case for NII ex-markets of approximately $107 billion.

JORDAN: And Barnum walked through the math on that. If you annualize the Q4 guide, you get to roughly $102 billion, so they're bridging about $5 billion of growth. About a quarter of that comes from rate hikes already priced into the forward curve — they're expecting one more hike in December and two more in the first half of next year. The rest is just continued balance sheet growth — deposits and card loans.

ALEX: But both Dimon and Barnum were careful to flag this is highly uncertain. Dimon specifically said there's "more uncertainty around that number than normal" given everything going on globally.

JORDAN: Now here's a strategic shift worth flagging — capital allocation. Buybacks dropped way down this quarter, from a normal cadence of around $7 billion to just $1 billion. That got a lot of investor questions.

ALEX: Right, and Dimon's answer was pretty clear: they estimate they're sitting on roughly $30 billion of excess capital, but they're choosing to redeploy it into organic growth rather than buybacks — specifically citing the "security resiliency initiative," a $1.5 trillion, 10-year commitment where they've already deployed over $200 billion in year one alone.

JORDAN: Barnum backed that up with context — JPMorgan's CET1 ratio has climbed from the high single digits years ago to 13.9% now, even while doing a lot of buybacks historically. The message is basically: when you can deploy capital internally at strong returns, that beats buying back stock at today's valuation.

ALEX: There was also a great exchange on AI. Analyst Mike Mayo pushed hard on quantifying AI's financial benefit, and Barnum was refreshingly candid — he said he's moving away from putting a specific dollar fi

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
Groups: PHARMA (https://betafinch.com/groups/PHARMA), INCOME (https://betafinch.com/groups/INCOME)
──────────
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, joined as always by Jordan, and today we're diving into Johnson & Johnson's third quarter 2026 results, reported Tuesday. Before we get going, a quick note — this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: And there's a lot to unpack here, Alex, because on the surface this looks like a messy quarter, but underneath it's actually a pretty strong one.

ALEX: Right, let's start with the headline numbers. J&J posted $25.4 billion in revenue for Q3, up 6% operationally, which actually beat analyst expectations. Management raised full-year guidance and now expects full-year operational sales growth of 6.7% to 7.1%, putting them on track to cross $100 billion in annual revenue for the very first time in the company's 140-year history.

JORDAN: That's a huge milestone. But here's where it gets messy — GAAP net earnings were just $210 million, and diluted EPS came in at nine cents, compared to $2.12 a year ago. That's a massive drop.

ALEX: And the reason is a one-time hit, not a business problem. J&J took a $5.5 billion charge tied to resolving the ovarian talc litigation, plus costs from two acquisitions — Firefly Bio in oncology and a collaboration with Cell BioMedicine in cell therapy. Strip those out, and adjusted EPS was $2.59, down about 7.5% year-over-year, but mostly because of those deal-related expenses, not underlying weakness.

JORDAN: Exactly. The core business is actually accelerating. Innovative Medicine — that's their pharma segment — grew 7.9% operationally to $16.8 billion, with eight brands growing double digits. Oncology alone grew 17%.

ALEX: Let's talk about the stars of the show. Tremfya, their immunology drug, grew 68% in the quarter. CARVYKTI, their multiple myeloma cell therapy, up 35%. And RYBREVANT, for lung cancer, up 64%. Tom Cavanaugh, the head of Innovative Medicine, specifically called out Icotrokinra — their new oral psoriasis treatment — saying it's tracking better than almost any launch they've seen in psoriatic disease, with over 20,000 patients started in just months.

JORDAN: What stood out to me is they're calling this a path to double-digit growth by 2030, and when an analyst from Goldman pressed CFO Joe Wolk on whether that assumes big acquisitions, he was pretty direct — no, it's organic. That's a meaningful claim given how reliant a lot of pharma growth stories are on M&A.

ALEX: Now, MedTech is the other side of the story, and it's where things got rockier. That division only grew 2.5%, missing expectations. Management was candid about it — Timothy Schmid, who runs MedTech, basically said "our performance is below the standard we set internally."

JORDAN: Two specific problem areas: international markets, especially due to disruption from the Middle East conflict affecting hospital purchasing and tender timing, and Abiomed, their heart pump business, which actually declined 1.5% because of a disputed study on high-risk PCI procedures. Execs pushed back hard on that study's methodology.

ALEX: But it wasn't all bad news in MedTech. Shockwave, their cardiovascular device business, grew 17%. And they got FDA clearance for Ottava, their new surgical robot — first commercial customer already signed. That's a big long-term bet on competing with Intuitive Surgical in robotics.

JORDAN: One housekeeping item investors should note — J&J confirmed they're still on track to spin off their orthopedics business, DePuy Synthes, by mid-2027, and they're leaning toward a straight spin-off rather than a sale.

ALEX: Let's hit a couple of Q&A highlights. On Icotrokinra,

This episode includes AI-generated content.

More earnings analysis: https://betafinch.com
──────────
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. Today we're digging into Intuit's fiscal fourth quarter and full-year 2026 results, reported after the bell on August 25th. Before we get into it — this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: And there's a lot to unpack here, Alex, because this isn't your typical "beat and raise" call. Intuit actually came out and said, "we messed up on customer growth, and we're resetting expectations."

ALEX: Right, let's start with the headline numbers. Full fiscal year 2026 revenue grew 14%, GAAP and non-GAAP diluted EPS both grew 20% for the year. Q4 specifically came in at $4.4 billion in revenue, up 14%, with non-GAAP operating income up 43% and non-GAAP EPS of $4.03, up 47% year over year.

JORDAN: Those are strong numbers on their face. But the stock-moving story here is what CEO Sasan Goodarzi called out directly: total online paying customers only grew 3% for the year — that's about two points slower than the prior year. And he was blunt about it, saying price is now the number one reason customers are leaving TurboTax for lower-cost competitors.

ALEX: Which is a pretty striking admission. For years Intuit's playbook was "upgrade customers into higher-value tiers." Now they're saying, actually, we lost quality DIY tax customers chasing that strategy, and we need to rebuild the funnel.

JORDAN: Exactly, and that shows up directly in guidance. For fiscal 2027, Intuit guided total company revenue growth of just 9% to 10% — a real deceleration from 14%. TurboTax revenue growth guided at only 2% to 3%, and they explicitly said they're accepting lower DIY tax ARPC on purpose to win back customers and gain e-file share.

ALEX: And it's not just consumer tax. On the business side, the Global Business Solutions long-term growth target got walked down too — last year they talked about 15% to 20% growth over the long run, now it's 10% to 15%.

JORDAN: Right, and an analyst, Raimo Lenschow from Barclays, asked exactly that on the call — is this pressure from new competitors? And Sasan pushed back pretty firmly, saying, quote, "we are creating the pressure, we are not being pressured to make the change." His argument is that Intuit spent the last few years building out mid-market and their "Big Bets" — assisted tax, money, and mid-market — which now make up 30% of revenue and are growing 34%. Now they want to layer back in aggressive new-customer acquisition at the low end, which they'd deprioritized.

ALEX: That's the strategic thread running through the whole call — this idea of "widening the front door." They launched QuickBooks Free and QuickBooks Lite, and management said they already have over 20,000 customers either active on the free tier or converted to paid in just the first month.

JORDAN: Small number today, but it's clearly meant to be a top-of-funnel signal. And on the consumer side, they're leaning on the fact that customers who use both TurboTax and Credit Karma generate roughly twice the revenue per customer of single-product users — so the bet is: take a lower margin tax customer now, cross-sell them into Credit Karma, loans, insurance, money products, and make it up on lifetime value.

ALEX: There were also some real organizational changes buried in here. Mailchimp is being split out as its own separate reportable segment starting fiscal 2027 instead of being folded into Global Business Solutions. And maybe more importantly for anyone tracking the numbers going forward — Intuit is now including stock-based compensation in its non-GAAP metrics, which it had excluded before.

JORDAN: That's a meaningful accounting shift. It's going to make non-GAAP EPS comparisons look different year over yea

This episode includes AI-generated content.